We have previously described the presence of an ectoenzyme system, consisting of nucleoside triphosphatase (EC 3.6.1.15), nucleoside diphosphatase (EC 3.6.1.6) and 5'-nucleotidase (EC 3.1.3.5) , that sequentially degrades extracellular ATP to adenosine at the surface of vascular endothelial cells and vascular smooth-muscle cells (Pearson et al., 1980) . Extracellular adenosine derivatives powerfully affect vascular tone and blood-platelet function. We therefore proposed that the endothelial ectoenzymes are involved in the regulation of these responses (for review see Pearson & Gordon, 1985) , a suggestion strengthened by the discovery that the vasodilator actions of ATP are endo- thelium-dependent and modulated via receptors on endothelial cells rather than on smooth muscle itself (DeMey & Vanhoutte, 1981; . In addition, both ATP and adenosine have been suggested to be neurotransmitters. ATP is released from nerve terminals and has been proposed as the non-cholinergic, non-adrenergic transmitter in several (including vascular) muscle beds, and both compounds can modulate the responses to other neurotransmitters (Burnstock, 1983) . Thus a regulatory role for smooth-musclecell ectonucleotidases in neurotransmission can be postulated; indeed, the original description of the purinergic transmitter hypothesis (Burnstock, 1972) required the presence of such enzymes, although they were not envisaged as occurring as an ectoenzyme system at the smooth-muscle-cell surface.
In the present paper we have extended our investigation of smooth-muscle-cell ectonucleotidases, in particular by using enantiomeric pairs of adenine nucleotide analogues in the manner that we have previously described for endothelial cells (Cusack et al., 1983) , to characterize the enzymes Vol. 230
and to discriminate between them and smoothmuscle-cell purinoceptors.
Materials and methods
Cell culture Endothelial cells or smooth-muscle cells were separately isolated from the aortas of newborn pigs and cultured as previously described (Pearson et al., 1978; . Cells were used for experiments after 2-17 passages.
Chemicals
[2-3H]AMP (sp. radioactivity 15-3OCi/mmol) was purchased from Amersham International. Other chemicals were from Sigma (London) Chemical Co., except for nucleotide analogues (phosphorothioates or L-nucleotides), which were synthesized as previously described (Holy & Sorm, 1971; Eckstein, 1979; Cusack et al., 1983; Cusack, 1985) .
Experiments
Cells grown in 16mm-diameter wells (approx. 105 cells/well) of 24-well tissue culture trays (Nunc) were used after removal of growth medium. After rinsing the cells with Dulbecco's phosphate-buffered saline containing 1.8mM-Ca2+ and 0.8mM-Mg2+ (Dulbecco & Vogt, 1954) , replicate incubations were carried out at 37°C in the same saline containing the appropriate nucleotides. Sub-samples of the incubation solutions were removed at timed intervals and stored at -20°C until required for analysis. In most experiments, catabolism of nucleotides or nucleotide analogues was assessed directly by h.p.l.c. separation of non-extracted subsamples, as previously described (Cusack et al., 1983). [3H]AMP catabolism was assessed by t.l.c. of sub-samples in the solvent system of Pull & Mcllwain (1972) , as described previously (Cusack et al., 1983) , except that glass-backed silica-gel layers were used. After drying the plates, radioactivity in each lane was monitored directly with a Berthold model LB2842 linear analyser. (Pearson et al., 1980) , and secondly because AMPS has been found not to be a substrate for such enzymes (Eckstein, 1975 (Pearson et al., 1980) . Fig. 1(b) (Cusack et al., 1983) .
Two other AMP analogues, 2-methylthio-AMPS and homo-AMP, were tested as potential (Eisenthal & Cornish-Bowden, 1974 (Fig. 3a) ; the product formed was predominantly L-ADP, with little L-AMP even after 180min. Confirming this, catabolism of exogenous L-ADP was detectable, but very slow by comparison with ADP (Fig. 3b) . We could not detect any catabolism of added L-AMP (Fig. 3c) (Cusack et al., 1983 
Discussion
The results reported here, in conjunction with those published previously (Pearson et al., 1980) counterparts in pig aortic endothelial cells. Thus, using L-nucleotides, we found that L-ATP is well catabolized and L-ADP less well by the smoothmuscle enzymes, exactly as is the case for the endothelial enzymes. Similarly, the pattern of stereoselectivity exhibited towards phosphorothioate analogues by the smooth-muscle ecto-triphosphatase and -diphosphatase is identical with that shown by the endothelial enzymes. The apparently contrasting stereoselectivity of the triphosphatase and the diphosphatase is due to an artefact of the S and R nomenclature: in each case the favoured isomer presents the same molecular configuration to the enzyme. The existence of stereoselectivity suggests that these ectoenzymes recognize ATP or ADP respectively complexed to Mg2+ in a specific manner (Eckstein, 1979) . Thus the reaction mechanisms for either ectoenzyme are likely to be very similar, if not identical, in both cell types, although their active-site substrate-binding properties -appear to be distinct. As noted above, in both cell types L-ATP is catabolized readily, whereas L-ADP is not. Furthermore, various ATP analogues selectively inhibit ADP catabolism, but the reverse is not true (Cusack et al., 1983; Pearson, 1985) . The ecto-5'-nucleotidase of aortic smoothmuscle cells exhibited clear differences from the endothelial enzyme. Its affinity for AMP (-230gM ) is about 10-fold lower in cultured smooth-muscle cells than in cultured endothelial cells, and its Vmax is more than 20-fold higher per cell, although we do not know whether this merely reflects a higher enzyme content. It is possible that the differences in kinetic parameters between endothelial and smooth-muscle cell ecto-5'-nucleotidases are not so great in vivo, because Km and Vmax. for the endothelial enzyme are known to decline substantially on culturing the cells (Hayes et al., 1979; Chesterman et al., 1983) , but the fact that the disparity is maintained when the cells are cultured under similar conditions in vitro suggests an inherent difference in enzyme properties.
In addition we found that smooth-muscle cells, but not endothelial cells, catabolized AMPS, and we confirmed that AMPS catabolism was due to 5'-nucleotidase, by inhibiting its breakdown with p[CH2]pA. Rather little work has been done on the interactions of AMPS with 5'-nucleotidase, but the purified enzyme from rat heart (where the cellular source is probably the myocyte, and the Km for AMP is 5-20gM) appears to behave similarly to the smooth-muscle-cell enzyme, in that it catabolizes AMPS with an affinity greater than that for AMP and a Vmax. about 6-36% that of AMP (Edwards & Maguire, 1970; Naito & Lowenstein, 1985) . As noted above, in previous studies of less specific phosphatases that dephosphorylate AMP, AMPS was not a substrate, but 5'-phosphorothioate nucleotides have been reported to be competitive inhibitors (Eckstein & Sternbach, 1967; Eckstein, 1975) . In our experiments AMPS inhibited 5'-nucleotidase in both vascular cell types, although it is not a substrate for the endothelial enzyme. Because of the importance of extracellular adenosine as a local signal in the induction of reactive hyperaemia, notably in the coronary bed (Berne, 1980) , there has been considerable interest in, and controversy concerning, the mechanism of adenosine production and the role of ecto-5'-nucleotidase in this process. There may be significant cellular compartmentation of adenosine turnover in the heart, and endothelial cells could play a major part under certain conditions (reviewed in Pearson & Gordon, 1985) . The finding that endothelial 5'-nucleotidase, unlike either the smooth-muscle or heart enzyme, binds but does not catabolize AMPS may be a clue indicating that the enzymes are differentially regulated in vivo.
Finally, there have been several suggestions that the magnitude of the pharmacological response to exogenous adenine nucleotides in various smoothmuscle beds is regulated by hydrolysis of the agonists, and hydrolysis of added ATP has been directly demonstrated in the urinary bladder (Cusack & Hourani, 1984) . The present study, by characterizing the properties of vascular smoothmuscle ectonucleotidases, will be useful in defining purinoceptor agonists whose activity cannot be limited by local catabolism, and hence in discriminating between the nucleotidases and purinoceptors at the smooth-muscle-cell surface.
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